PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 56 filers reported holding PROQR THRAPEUTICS N V in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $26,448 | -33.7% | 15,932 | -8.5% | 0.00% | – |
| Q1 2024 | $39,890 | +15.7% | 17,420 | 0.0% | 0.00% | – |
| Q4 2023 | $34,492 | +52.3% | 17,420 | 0.0% | 0.00% | – |
| Q3 2023 | $22,646 | -19.8% | 17,420 | 0.0% | 0.00% | – |
| Q2 2023 | $28,221 | +17.8% | 17,420 | +54.9% | 0.00% | – |
| Q1 2023 | $23,958 | -53.0% | 11,248 | +77.7% | 0.00% | – |
| Q4 2021 | $51,000 | -44.0% | 6,330 | -53.0% | 0.00% | – |
| Q2 2021 | $91,000 | -22.9% | 13,481 | -24.7% | 0.00% | – |
| Q1 2021 | $118,000 | -47.1% | 17,913 | -53.8% | 0.00% | – |
| Q3 2019 | $223,000 | -36.8% | 38,742 | 0.0% | 0.00% | – |
| Q2 2019 | $353,000 | -26.0% | 38,742 | +12.6% | 0.00% | – |
| Q1 2019 | $477,000 | -28.4% | 34,397 | -18.5% | 0.00% | – |
| Q4 2018 | $666,000 | – | 42,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copernicus Capital Management, LLC | 40,000 | $335,000 | 4.05% |
| Opaleye Management Inc. | 1,424,200 | $11,921,000 | 2.23% |
| Prosight Management, LP | 282,256 | $2,362,000 | 1.30% |
| RTW INVESTMENTS, LP | 6,443,113 | $53,929,000 | 0.81% |
| DAFNA Capital Management LLC | 296,383 | $2,481,000 | 0.66% |
| Kerrisdale Advisers, LLC | 453,182 | $3,793,000 | 0.41% |
| Altium Capital Management LP | 125,000 | $1,046,000 | 0.27% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,079,668 | $17,407,000 | 0.21% |
| Alpha Paradigm Partners, LLC | 44,323 | $371,000,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 137,003 | $1,147,000 | 0.12% |